SCHEMBL5201383

SCHEMBL5201383

O=C(O)C1CCN1C(=S)c1cccc(C(F)(F)C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.38
RBP4 P02753 1/20 0.38
HSD11B1 P28845 1/20 0.38
MGLL Q99685 1/20 0.38
SRD5A2 P31213 1/20 0.37
NOTUM Q6P988 1/20 0.37
CES2 O00748 1/20 0.36
LOXL2 Q9Y4K0 2/20 0.36
DGAT1 O75907 1/20 0.36
CNR2 P34972 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3550632 0.87 LMNA (0.38) LMNAPOLBHPGDKMT2ARBP4
SCHEMBL3550630 0.87 LMNA (0.38) LMNAPOLBHPGDKMT2ARBP4
SCHEMBL3544419 0.86 PDK2 (0.45) LMNAPOLBHPGDKMT2ARBP4
Hydroxyamine SCHEMBL5238906 0.81 LMNA (0.50) LMNAPOLBHPGDKMT2ARBP4
Hydroxyamine SCHEMBL5238910 0.81 LMNA (0.50) LMNAPOLBHPGDKMT2ARBP4
SCHEMBL3548147 0.77 LMNA (0.48) LMNAPOLBHPGDKMT2ARBP4
SCHEMBL3548145 0.77 LMNA (0.48) LMNAPOLBHPGDKMT2ARBP4
Hydroxyamine SCHEMBL5236480 0.77 TACR1 (0.43) POLBCES2
SCHEMBL3547423 0.76 LMNA (0.47) LMNAPOLBHPGDKMT2ARBP4
SCHEMBL3547425 0.76 LMNA (0.47) LMNAPOLBHPGDKMT2ARBP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539744-A4 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARM INC (US) 2007-06-06 EP disclosed
EP-1539744-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2005-06-15 EP disclosed
WO-2004007444-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2004-01-22 WO disclosed